Cargando…

Liver in the limelight in the corona (COVID-19) time

The novel coronavirus, severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2), is a topic of great interest currently in the medical field due to the significant morbidity and mortality associated with it. There is immense curiosity about this virus as knowledge about it is limited from patho...

Descripción completa

Detalles Bibliográficos
Autores principales: Chela, Harleen Kaur, Pasha, Syed Bilal, Basar, Omer, Daglilar, Ebubekir, Tahan, Veysel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457103/
https://www.ncbi.nlm.nih.gov/pubmed/32913847
http://dx.doi.org/10.12998/wjcc.v8.i16.3405
_version_ 1783575935442747392
author Chela, Harleen Kaur
Pasha, Syed Bilal
Basar, Omer
Daglilar, Ebubekir
Tahan, Veysel
author_facet Chela, Harleen Kaur
Pasha, Syed Bilal
Basar, Omer
Daglilar, Ebubekir
Tahan, Veysel
author_sort Chela, Harleen Kaur
collection PubMed
description The novel coronavirus, severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2), is a topic of great interest currently in the medical field due to the significant morbidity and mortality associated with it. There is immense curiosity about this virus as knowledge about it is limited from pathogenesis, host related factors and the variable effect it has on different patient populations. Though it has claimed fame due to its ability to compromise the respiratory system, it possess the capability to infect other organs as well including the liver. It is important for clinicians to recognize that the virus can result in multi-organ dysfunction as well. Presentation with gastrointestinal symptoms and involvement of the liver can be subtle and can be misdiagnosed. Those with pre-existing liver disease may be more susceptible as well as those who are immunosuppressed or have other co-morbidities. This review article provides a brief overview of some of the information that is available so far with regards to how the liver is impacted by the coronavirus.
format Online
Article
Text
id pubmed-7457103
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-74571032020-09-09 Liver in the limelight in the corona (COVID-19) time Chela, Harleen Kaur Pasha, Syed Bilal Basar, Omer Daglilar, Ebubekir Tahan, Veysel World J Clin Cases Minireviews The novel coronavirus, severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2), is a topic of great interest currently in the medical field due to the significant morbidity and mortality associated with it. There is immense curiosity about this virus as knowledge about it is limited from pathogenesis, host related factors and the variable effect it has on different patient populations. Though it has claimed fame due to its ability to compromise the respiratory system, it possess the capability to infect other organs as well including the liver. It is important for clinicians to recognize that the virus can result in multi-organ dysfunction as well. Presentation with gastrointestinal symptoms and involvement of the liver can be subtle and can be misdiagnosed. Those with pre-existing liver disease may be more susceptible as well as those who are immunosuppressed or have other co-morbidities. This review article provides a brief overview of some of the information that is available so far with regards to how the liver is impacted by the coronavirus. Baishideng Publishing Group Inc 2020-08-26 2020-08-26 /pmc/articles/PMC7457103/ /pubmed/32913847 http://dx.doi.org/10.12998/wjcc.v8.i16.3405 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Minireviews
Chela, Harleen Kaur
Pasha, Syed Bilal
Basar, Omer
Daglilar, Ebubekir
Tahan, Veysel
Liver in the limelight in the corona (COVID-19) time
title Liver in the limelight in the corona (COVID-19) time
title_full Liver in the limelight in the corona (COVID-19) time
title_fullStr Liver in the limelight in the corona (COVID-19) time
title_full_unstemmed Liver in the limelight in the corona (COVID-19) time
title_short Liver in the limelight in the corona (COVID-19) time
title_sort liver in the limelight in the corona (covid-19) time
topic Minireviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457103/
https://www.ncbi.nlm.nih.gov/pubmed/32913847
http://dx.doi.org/10.12998/wjcc.v8.i16.3405
work_keys_str_mv AT chelaharleenkaur liverinthelimelightinthecoronacovid19time
AT pashasyedbilal liverinthelimelightinthecoronacovid19time
AT basaromer liverinthelimelightinthecoronacovid19time
AT daglilarebubekir liverinthelimelightinthecoronacovid19time
AT tahanveysel liverinthelimelightinthecoronacovid19time